Page last updated: 2024-11-07

ambrox

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ambrox is a synthetic molecule with a woody, ambery odor. It is often used in perfumery as a fixative and to impart a warm, sensual base note to fragrances. Ambrox is a derivative of the natural compound ambrein, which is found in ambergris, a waxy substance produced in the digestive tract of sperm whales. Ambrox is synthesized from sclareol, a naturally occurring diterpene alcohol found in clary sage. The synthesis involves several steps, including oxidation, dehydration, and ring closure. Ambrox is considered a safer alternative to ambergris, as it does not involve harvesting from endangered species. It has gained popularity in the fragrance industry due to its potent odor, versatility, and lasting power. Research on ambrox focuses on optimizing its synthesis, exploring its potential biological activities, and developing new applications in various fields, including cosmetics, pharmaceuticals, and food.'

ambrox: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107166
CHEMBL ID3728760
CHEBI ID171882
SCHEMBL ID236500
MeSH IDM0370166

Synonyms (38)

Synonym
naphtho[2,1-b]furan, dodecahydro-3a,6,6,9a-tetramethyl-
ambronide
3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1h-benzo[e][1]benzouran
3738-00-9
CHEBI:171882
ambrox
AKOS000621409
mfcd01079752
3a,6,6,9a-tetramethylperhydronaphtho[2,1-b]furan
3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1h-benzo[e][1]benzofuran
3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1h-benzo[e]benzofuran
einecs 223-118-6
ambrox dl
amberlyn
dodecahydro-3a,6,6,9a-tetramethylnaphtho(2,1-beta)furan
dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
cetalox
ambrotech
ec 223-118-6
naphtho(2,1-b)furan, dodecahydro-3a,6,6,9a-tetramethyl-
dodecahydrotetramethyl naphthofuran
dodecahydro-3a,6,6,9a-tetramethylnaphtho(2,1-b)furan
tetramethyl-perhydronaphthofuran
FT-0625565
FT-0625564
1,5,5,9-tetramethyl-13-oxatricyclo[8.3.0.04,9]tridecane
SCHEMBL236500
dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan
3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan
DTXSID2048119
AKOS024304456
dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-.beta.]furan
(?)-ambroxide
3a,6,6,9a-tetramethyl-dodecahydronaphtho[2,1-b]furan
CHEMBL3728760
fema 3471
n-epoxide
bicyclofarnesyl epoxide

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
naphthofuran
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (33.33)29.6817
2010's6 (40.00)24.3611
2020's4 (26.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 71.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index71.82 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index140.16 (26.88)
Search Engine Supply Index2.36 (0.95)

This Compound (71.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (25.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]